Is this your brand? Sign in to claim ownership.

Sign in to claim this brand

Levins Pharmaceuticals LLC

US

Last updated May 31, 2026

What Levins Pharmaceuticals LLC makes

Levins Pharmaceuticals LLC manufactures the Iliderm Rx Skin Emulsion, which is a skin osmotic dressing that is non-sterile.

The company is based in the US and its product is classified as a Class U device, listed in the FDA UDI registry.

Written from this company's registered devices by an AI model, and not verified by a human reviewer.

Frequently asked questions

What does Levins Pharmaceuticals LLC manufacture?

Levins Pharmaceuticals LLC manufactures the Iliderm Rx Skin Emulsion, which is a skin osmotic dressing that is non-sterile. This product is designed for specific skin care applications.

Where is Levins Pharmaceuticals LLC based?

Levins Pharmaceuticals LLC is based in the United States. The company operates within the US market, focusing on the development and distribution of its medical devices.

Which regulatory registries list Levins Pharmaceuticals LLC's devices?

Levins Pharmaceuticals LLC's devices are listed in the FDA UDI registry. This registry tracks unique device identifiers for medical devices sold in the United States.

How are Levins Pharmaceuticals LLC's devices classified?

Levins Pharmaceuticals LLC's devices, such as the Iliderm Rx Skin Emulsion, are classified as Class U devices. This classification indicates the regulatory category assigned to the product based on its intended use and potential risks.

AI-generated from registry data and not verified by a human reviewer.

Information

Country
US
Address
—
Website
—
LinkedIn
—
Facebook
—
Email
—
Phone
—
PRRC Contact
—
EUDAMED SRN
—
FDA FEI Number
—
DUNS Number
080839485

Catalogue (1)

DeviceModel / ReferenceRegistriesClassStatus
Iliderm Rx Skin Emulsion D0005
FDA UDI
UActive

Related Companies

Authorised Representatives

No authorised representatives on record.

Importers

Not available yet.

Notified Bodies

Not available yet.

Authorities

Not available yet.